Log in

NYSEARCA:VXXIPATH Series B S&P 500 VIX Short-Term Futures ETN Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range
$26.53
MA: $31.96
$37.50
52-Week Range N/A
Volume29.49 million shs
Average Volume41.40 million shs
Market Capitalization$894.75 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A


Basic Details

Issuer
Fund NameIPATH Series B S&P 500 VIX Short-Term Futures ETN
Tax Classification
SymbolNYSEARCA:VXX
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$984.36 million
Average Daily Volume$30.66 million
Discount/Premium-7.91%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker
30 days | 90 days | 365 days | Advanced Chart

Receive VXX News and Ratings via Email

Sign-up to receive the latest news and ratings for VXX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IPATH Series B S&P 500 VIX Short-Term Futures ETN (NYSEARCA:VXX) Frequently Asked Questions

Has IPATH Series B S&P 500 VIX Short-Term Futures ETN been receiving favorable news coverage?

News stories about VXX stock have trended somewhat negative on Tuesday, InfoTrie reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. IPATH Series B S&P 500 VIX Short-Term Futures ETN earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about IPATH Series B S&P 500 VIX Short-Term Futures ETN
.

What other stocks do shareholders of IPATH Series B S&P 500 VIX Short-Term Futures ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IPATH Series B S&P 500 VIX Short-Term Futures ETN investors own include NVIDIA (NVDA), Netflix (NFLX), Tesla (TSLA), SPDR S&P 500 ETF Trust (SPY), Alibaba Group (BABA), Micron Technology (MU), Bank of America (BAC), Invesco QQQ Trust (QQQ), General Electric (GE) and Walt Disney (DIS).

What is IPATH Series B S&P 500 VIX Short-Term Futures ETN's stock symbol?

IPATH Series B S&P 500 VIX Short-Term Futures ETN trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "VXX."

Who are IPATH Series B S&P 500 VIX Short-Term Futures ETN's major shareholders?

IPATH Series B S&P 500 VIX Short-Term Futures ETN's stock is owned by many different retail and institutional investors. Top institutional shareholders include JBF Capital Inc. (0.14%) and North Star Investment Management Corp. (0.03%).

Which institutional investors are selling IPATH Series B S&P 500 VIX Short-Term Futures ETN stock?

VXX stock was sold by a variety of institutional investors in the last quarter, including JBF Capital Inc..

Which institutional investors are buying IPATH Series B S&P 500 VIX Short-Term Futures ETN stock?

VXX stock was acquired by a variety of institutional investors in the last quarter, including North Star Investment Management Corp..

How do I buy shares of IPATH Series B S&P 500 VIX Short-Term Futures ETN?

Shares of VXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is IPATH Series B S&P 500 VIX Short-Term Futures ETN?

IPATH Series B S&P 500 VIX Short-Term Futures ETN has a market capitalization of $0.00.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.